In addition to its effects on insulin and glucagon, GLP-1 exhibits a wide range of actions, including promoting insulin sensitivity in the adipose tissue, stimulating energy expenditure and fat breakdown, reducing hepatic steatosis and liver lipid content, and delaying gastric emptying. Here, GCG is linked to fatty liver disease.